The U.S. Food and Drug Administration (FDA) has had a busy August. In addition to the number of draft guidances the agency issued during the month, the FDA has also been busy approving a number of new treatments for a variety of diseases.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,